Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 AACR highlights: promise for treating pancreatic cancer.

× No keyword cloud information.

4 in total

Review 1. Nanomedicine strategies to overcome the pathophysiological barriers of pancreatic cancer.

Authors: Pavan P Adiseshaiah; Rachael M Crist; Sara S Hook; Scott E McNeil
Journal: Nat Rev Clin Oncol Date: 2016-08-17 Impact factor: 66.675

2. Growth inhibition of pancreatic cancer cells by histone deacetylase inhibitor belinostat through suppression of multiple pathways including HIF, NFkB, and mTOR signaling in vitro and in vivo.

Authors: Wenwen Chien; Dhong Hyun Lee; Yun Zheng; Peer Wuensche; Rosie Alvarez; Ding Ling Wen; Ahmed M Aribi; Su Ming Thean; Ngan B Doan; Jonathan W Said; H Phillip Koeffler
Journal: Mol Carcinog Date: 2013-03-08 Impact factor: 4.784

3. Tumor targeting Salmonella typhimurium A1-R in combination with gemcitabine (GEM) regresses partially GEM-resistant pancreatic cancer patient-derived orthotopic xenograft (PDOX) nude mouse models.

Authors: Kei Kawaguchi; Kentaro Miyake; Ming Zhao; Tasuku Kiyuna; Kentaro Igarashi; Masuyo Miyake; Takashi Higuchi; Hiromichi Oshiro; Michael Bouvet; Michiaki Unno; Robert M Hoffman
Journal: Cell Cycle Date: 2018-09-19 Impact factor: 4.534

4. MEK inhibitors cobimetinib and trametinib, regressed a gemcitabine-resistant pancreatic-cancer patient-derived orthotopic xenograft (PDOX).

Authors: Kei Kawaguchi; Kentaro Igarashi; Takashi Murakami; Tasuku Kiyuna; Thinzar M Lwin; Ho Kyoung Hwang; Jonathan C Delong; Bryan M Clary; Michael Bouvet; Michiaki Unno; Robert M Hoffman
Journal: Oncotarget Date: 2017-07-18

4 in total